Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities
Net income (loss)	$ 947,415	$ (2,045,385)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	218,871	126,866
Restricted stock issuance	221,893	0
Stock compensation expense	631,414	615,619
Change in operating assets and liabilities:
Decrease in accounts receivable	0	4,550
Decrease in prepaid assets and other current assets	160,320	0
Increase in accounts payable	70,835	14,226
Increase in bonus accrual	273,675	0
Net cash provided by (used in) operating activities	2,524,423	(1,284,124)
Cash flows from investing activities
Purchase of property and equipment	(2,364,060)	(14,071)
Net cash used in investing activities	(2,364,060)	(14,071)
Cash flows from financing activities
Proceeds from exercise of warrants, net	115,982	0
Proceeds from exercise of stock options, net	2,431,239	0
Net cash provided by financing activities	2,547,221	0
Net increase (decrease) in cash and cash equivalents	2,707,584	(1,298,195)
Cash and cash equivalents, beginning of period	13,000,372	7,216,663
Cash and cash equivalents, end of period	15,707,956	5,918,468
Supplemental disclosures of cash flow information:
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Supplemental disclosures of non-cash financing information:
Issuance of 137,778 shares of common stock in exchange for the cashless exercise of warrants to purchase 198,721 shares of common stock	$ 771,253	$ 0